Australia's OBJ Ltd. said Chairman Glyn Denison stepped down from the board Feb. 2.
Denison served on the company's board for 12 years, and first stated his intention to retire in August 2017.
OBJ develops drug and ingredient delivery technologies for pharmaceutical, healthcare, cosmetic and homecare applications.
